A Phase II Study to Evaluate the Safety and Efficacy of Pegteograstim in Korean Breast Cancer Patients Receiving Dose-Dense Doxorubicin/Cyclophosphamide

PURPOSE: Dose-dense chemotherapy (DD-CT) is a preferred (neo)adjuvant regimen in early breast cancer (BC). Although the results of reported randomized trials are conflicting, a recent metaanalysis showed improved overall and disease-free survival with DD-CT compared to conventional schedules. Howeve...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Cancer Res Treat
Главные авторы: Kim, Gun Min, Kim, Joo Hoon, Kim, Ji Heung, Cho, Young Up, Kim, Seung Il, Park, Seho, Park, Hyung Seok, Kim, Ji Ye, Sohn, Joohyuk
Формат: Artigo
Язык:Inglês
Опубликовано: Korean Cancer Association 2019
Предметы:
Original Article
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC6473288/
https://ncbi.nlm.nih.gov/pubmed/30235921
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4143/crt.2018.383
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы